Complix
Manufacturing · Belgium · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Technologiepark 94, Gent Zwijnaarde, Fla...Phone Number
+32 92616940Website
www.complix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Complix
Complix is a biopharmaceutical company specializing in the development of transformative Cell Penetrating Alphabody (CPAB) therapeutics aimed at addressing challenging intracellular targets associated with life-threatening diseases, particularly cancer and autoimmune disorders. Their proprietary technology allows for the targeting of previously undruggable disease targets and offers innovative delivery methods, including non-injectable options. Complix is actively developing a pipeline of product candidates and seeks partnerships to enhance the potential of its Alphabody platform. The company is committed to creating novel therapeutic interventions that expand the reach of biopharmaceuticals beyond traditional limitations.Explore more
Complix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Complix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Complix had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Complix launches new products
Congratulate Masked Content for being promoted to Masked Content at Complix
Funding: Get notified immidiatlly once Complix has new funding data
Check if Complix has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Complix recently announced quarterly report
Complix, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Complix is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Complix
Find more new buyers
Company Profile Activity
Activity Insights
Complix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Complix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Complix.
Complix financials insights
Gather financial insights about Complix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Series A
$6.2M
2013
Series B
$15.5M
2017
Grant
$600K
Complix Tech Stack
A closer look at the technologies used by Complix
Complix News & Media
Complix and VIB Publish Pioneering Study on Cell-Penetrating Alphabodies in Science Advances
HASSELT, Belgium, March 31, 2021 /PRNewswire/ -- Complix, a biopharmaceutical company developing a pipeline of transformative Alphabody therapeutics announces the publication in Science Advances of the results from a joint, multidisciplinary study with Belgian life sciences research...Complix Signs Global Drug Discovery and Development Agreement with I-Mab to Develop Cell Penetrating Alphabodies against Two Intracellular Immuno-oncology Targets
HASSELT, Belgium, March 10, 2021 /PRNewswire/ -- Complix, a biopharmaceutical company developing a pipeline of transformative Alphabody therapeutics announces that it has signed a significant drug discovery deal with I-Mab (Nasdaq: IMAB), an innovation-driven clinical stage...I-Mab Launches Discovery Initiative to Expand Transformational Immuno-Oncology Pipeline
- New Initiative is part of I-Mab’s long-term strategy to drive innovation and scientific leadership in immuno-oncology - New collaborations signed will allow I-Mab access to cutting edge technology platforms to develop novel drug molecules - I-Mab continues to focus on delivering on key clinical programs while building pipeline of next generation assetsTop Biotech Companies Riding High in Belgium
Meet the most successful biotech companies in Belgium, a small country that makes a huge contribution to the European biotech industry.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Complix
Sign Up For FreeTo access detailed company insights
Complix is a biopharmaceutical company specializing in the development of transformative Cell Penetrating Alphabody (CPAB) therapeutics aimed at addressing challenging intracellular targets associated with life-threatening diseases, particularly cancer and autoimmune disorders. Their proprietary technology allows for the targeting of previously und... Read More
